MGMT and neoplasm: Furthermore, cotreatment of tumours with O6-benzylguanine, another otherwise nontoxic inhibitor of MGMT, increases the sensitivity of MGMT positive cells towards temozolomide (Dolan et al, 1990; Tentori et al, 1997).